Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease.
Villella VR, Venerando A, Cozza G, Esposito S, Ferrari E, Monzani R, Spinella MC, Oikonomou V, Renga G, Tosco A, Rossin F, Guido S, Silano M, Garaci E, Chao YK, Grimm C, Luciani A, Romani L, Piacentini M, Raia V, Kroemer G, Maiuri L. Villella VR, et al. Among authors: garaci e. EMBO J. 2019 Jan 15;38(2):e100101. doi: 10.15252/embj.2018100101. Epub 2018 Nov 29. EMBO J. 2019. PMID: 30498130 Free PMC article.
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.
Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E. Romani L, et al. Among authors: garaci e. Nat Med. 2017 May;23(5):590-600. doi: 10.1038/nm.4305. Epub 2017 Apr 10. Nat Med. 2017. PMID: 28394330 Free PMC article.
IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut.
Renga G, Moretti S, Oikonomou V, Borghi M, Zelante T, Paolicelli G, Costantini C, De Zuani M, Villella VR, Raia V, Del Sordo R, Bartoli A, Baldoni M, Renauld JC, Sidoni A, Garaci E, Maiuri L, Pucillo C, Romani L. Renga G, et al. Among authors: garaci e. Cell Rep. 2018 May 8;23(6):1767-1778. doi: 10.1016/j.celrep.2018.04.034. Cell Rep. 2018. PMID: 29742432 Free PMC article.
Reply to 'F508del-CFTR is not corrected by thymosin α1'.
Romani L, Stincardini C, Giovagnoli S, Paci M, Villella VR, Sforna L, Renga G, Bellet MM, Costantini C, Puccetti P, Kroemer G, Maiuri L, Pessia M, Goldstein A, Garaci E. Romani L, et al. Among authors: garaci e. Nat Med. 2018 Jul;24(7):891-893. doi: 10.1038/s41591-018-0080-0. Nat Med. 2018. PMID: 29942090 No abstract available.
Thymosin β4 limits inflammation through autophagy.
Renga G, Oikonomou V, Stincardini C, Pariano M, Borghi M, Costantini C, Bartoli A, Garaci E, Goldstein AL, Romani L. Renga G, et al. Among authors: garaci e. Expert Opin Biol Ther. 2018 Jul;18(sup1):171-175. doi: 10.1080/14712598.2018.1473854. Expert Opin Biol Ther. 2018. PMID: 30063848 Review.
Cellular proteostasis: a new twist in the action of thymosin α1.
Stincardini C, Renga G, Villella V, Pariano M, Oikonomou V, Borghi M, Bellet MM, Sforna L, Costantini C, Goldstein AL, Garaci E, Romani L. Stincardini C, et al. Among authors: garaci e. Expert Opin Biol Ther. 2018 Jul;18(sup1):43-48. doi: 10.1080/14712598.2018.1484103. Expert Opin Biol Ther. 2018. PMID: 30063867 Review.
Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis.
Bellet MM, Borghi M, Pariano M, Renga G, Stincardini C, D'Onofrio F, Brancorsini S, Garaci E, Costantini C, Romani L. Bellet MM, et al. Among authors: garaci e. Eur J Med Chem. 2021 Jan 1;209:112921. doi: 10.1016/j.ejmech.2020.112921. Epub 2020 Oct 9. Eur J Med Chem. 2021. PMID: 33071052
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.
Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E. Romani L, et al. Among authors: garaci e. Nat Med. 2018 Sep;24(9):1481. doi: 10.1038/s41591-018-0100-0. Nat Med. 2018. PMID: 29934534
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.
Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E. Romani L, et al. Among authors: garaci e. Nat Med. 2018 Sep;24(9):1482. doi: 10.1038/s41591-018-0099-2. Nat Med. 2018. PMID: 29934535
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease.
Renga G, Oikonomou V, Moretti S, Stincardini C, Bellet MM, Pariano M, Bartoli A, Brancorsini S, Mosci P, Finocchi A, Rossi P, Costantini C, Garaci E, Goldstein AL, Romani L. Renga G, et al. Among authors: garaci e. Life Sci Alliance. 2019 Nov 12;2(6):e201900432. doi: 10.26508/lsa.201900432. Print 2019 Dec. Life Sci Alliance. 2019. PMID: 31719116 Free PMC article.
328 results